Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network-Reference-Cited by-同舟云学术

Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network

Published:2011-08-24 Issue:9 Volume:52 Page:1675-1680
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kenkre Vaishalee P.,Long Walter L.,Eickhoff Jens C.,Blank Jules H.,McFarland Thomas A.,Bottner Wayne,Rezazedeh Hamied,Werndli Jae E.,Bailey Howard H.,Kahl Brad S.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.580404

Reference27 articles.

1. The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non-intensive therapy by the British National Lymphoma Investigation Group

2. Patterns of survival in mantle cell lymphoma

3. Mantle cell lymphoma-- an entity comes of age

4. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group

5. Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mantle cell lymphoma;Critical Reviews in Oncology/Hematology;2020-09

2. Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study;Advances in Therapy;2020-05-12

3. Management of Older Adults with Mantle Cell Lymphoma;Drugs & Aging;2020-05-05

4. Risk - adapted intensive induction therapy, autologous stem cell transplantation, and rituximab maintenance allow to reach a high 7-year survival rate in patients with mantle cell lymphoma;Terapevticheskii arkhiv;2019-07-15

5. Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry†;Leukemia & Lymphoma;2018-09-06